SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System View more
RION Announces Initiation of Phase 2A Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers View more
Medical Alley Appoints James Hereford as Board Chair, Scott Cundy, Heidi Dieter, and Aaron Hudy to Board of Directors View more
NMDP BioTherapiesSM Appoints New President to Lead Next Phase in Life-Saving Therapy Development View more
